GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (FRA:17D) » Definitions » Cyclically Adjusted Price-to-FCF

Arcadia Biosciences (FRA:17D) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Arcadia Biosciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Arcadia Biosciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Cyclically Adjusted Price-to-FCF Chart

Arcadia Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Arcadia Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Arcadia Biosciences's Cyclically Adjusted Price-to-FCF

For the Packaged Foods subindustry, Arcadia Biosciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences's Cyclically Adjusted Price-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Cyclically Adjusted Price-to-FCF falls into.



Arcadia Biosciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Arcadia Biosciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Arcadia Biosciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.177/131.7762*131.7762
=-2.177

Current CPI (Mar. 2024) = 131.7762.

Arcadia Biosciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -113.049 100.560 -148.143
201409 -70.146 100.428 -92.042
201412 -52.585 99.070 -69.945
201503 -50.146 99.621 -66.332
201506 -118.800 100.684 -155.487
201509 -75.145 100.392 -98.637
201512 -67.036 99.792 -88.521
201603 -81.509 100.470 -106.907
201606 -65.582 101.688 -84.987
201609 -64.073 101.861 -82.890
201612 -72.571 101.863 -93.883
201703 -77.982 102.862 -99.902
201706 -73.679 103.349 -93.945
201709 -37.736 104.136 -47.752
201712 -42.811 104.011 -54.239
201803 -39.073 105.290 -48.902
201806 -44.723 106.317 -55.433
201809 -29.084 106.507 -35.984
201812 -20.925 105.998 -26.014
201903 -30.176 107.251 -37.077
201906 -32.921 108.070 -40.143
201909 -22.540 108.329 -27.419
201912 -23.272 108.420 -28.285
202003 -41.903 108.902 -50.705
202006 -31.438 108.767 -38.088
202009 -22.832 109.815 -27.398
202012 -20.838 109.897 -24.987
202103 -9.162 111.754 -10.803
202106 -9.857 114.631 -11.331
202109 -13.002 115.734 -14.804
202112 -10.760 117.630 -12.054
202203 -8.058 121.301 -8.754
202206 -5.746 125.017 -6.057
202209 -5.546 125.227 -5.836
202212 -3.337 125.222 -3.512
202303 -3.747 127.348 -3.877
202306 -3.261 128.729 -3.338
202309 -1.988 129.860 -2.017
202312 -2.791 129.419 -2.842
202403 -2.177 131.776 -2.177

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Arcadia Biosciences  (FRA:17D) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Arcadia Biosciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcadia Biosciences (FRA:17D) Business Description

Traded in Other Exchanges
Address
5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Arcadia Biosciences (FRA:17D) Headlines

No Headlines